Status:

COMPLETED

Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen

Lead Sponsor:

Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

Collaborating Sponsors:

Sanofi

Conditions:

Diabetes

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of the TELESAGE study is to demonstrate 1. the superiority of follow up with the DIABEO system (software alone) versus usual follow up in terms of improvement in HbA1c after 1 year in DM1 or ...

Eligibility Criteria

Inclusion

  • Type 1 or type 2 diabetic patients
  • Performing auto-glycaemic control (at least 2 glycemias a day)
  • Treated with insulin by a basal-bolus regimen for at least 1 year and using the same method of administration for at least 3 months (insulin pen or pump)
  • Who have an Apple® or Androïde® Smartphone compatible, or intend to acquire one before their participation in the study
  • Whose HbA1c dating of less 1 month and more than 3 months is ≥ 8%
  • Who are able to understand and follow the study protocol
  • Who have given their signed consent to take part in the study
  • Subject affiliated to the French National Health Insurance funds or benefiting from such insurance

Exclusion

  • Age \< 18 years old
  • Patients who have used the DIABEO system within 6 months before inclusion
  • Participation in a clinical study within 6 months, except for the Meos (or télédiab 3) study after a participation period of 6 months
  • Patients who are pregnant or who wish to become pregnant during the study.
  • Patients treated with human insulin A patient pre-screening register will be set up in each centre to establish the reasons for DM1/DM2 patients treated with a basal-bolus insulin regimen who are not taking part in the study.

Key Trial Info

Start Date :

February 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 27 2018

Estimated Enrollment :

667 Patients enrolled

Trial Details

Trial ID

NCT02287532

Start Date

February 1 2013

End Date

July 27 2018

Last Update

August 21 2018

Active Locations (108)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 27 (108 locations)

1

Centre hospitalier du Pays d'Aix

Aix-en-Provence, France, 13616

2

Clinique Claude Bernard

Albi, France, 81030

3

CHI d'Alencon

Alençon, France, 61014

4

Centre hospitalier d'Ales

Alès, France, 30103

Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen | DecenTrialz